6 Fuk Wang Street
Yuen Long Industrial Estate
Yuen Long
Hong Kong
852 2687 1033
https://www.tul.com.cn
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 15,000
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Hoi Shan Tsoi | Executive Chairman | 4.32M | N/A | 1978 |
Mr. Wing Hon Leung CPA, FCPA | Vice Chairman, CFO & Company Secretary | 4.29M | N/A | 1962 |
Ms. Su Yan Zhu | VP & Executive Director | 2.62M | N/A | 1965 |
Ms. Xian Hong Zou | VP & Executive Director | 2.62M | N/A | 1965 |
Ms. Siu Chit Choy | Global Director of Intermediate & Bulk Medicine and Executive Director | 2.87M | N/A | 1973 |
Mr. Yu Ping Fang | VP & Executive Director | 2.67M | N/A | 1963 |
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules, as well as active pharmaceutical ingredients and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, rest of Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
The United Laboratories International Holdings Limited’s ISS governance QualityScore as of 1 May 2024 is 9. The pillar scores are Audit: 7; Board: 5; Shareholder rights: 7; Compensation: 10.